Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Notes Payables (2023 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Notes Payables for 3 consecutive years, with $28.2 million as the latest value for Q4 2025.

  • Quarterly Notes Payables changed N/A to $28.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $28.2 million for FY2025, N/A changed from the prior year.
  • Notes Payables for Q4 2025 was $28.2 million at Werewolf Therapeutics, up from $6.0 million in the prior quarter.
  • The five-year high for Notes Payables was $28.2 million in Q4 2025, with the low at $1.7 million in Q3 2023.
  • Average Notes Payables over 3 years is $9.4 million, with a median of $6.3 million recorded in 2023.